Abstract: As one of the most basic and widely used instruments in the medical field, the evolution history of subcutaneous injection needle materials is almost a miniature history of modern materials science development. Since the invention of the first generation of syringes by Charles Pravaz and Alexander Wood in the mid-19th century, the material selection of injection needles has developed from simple metal processing to a high-tech field involving interdisciplinary integration of biocompatibility, mechanical properties, surface treatment and other aspects. This paper systematically reviews the evolutionary process of subcutaneous injection needle materials, focuses on the technical logic of stainless steel as the dominant material, the precise application of special alloys, the breakthrough progress of polymer materials and the development of surface engineering technology, and looks forward to the future development trend of intelligent response materials and integrated structure-function design. It is pointed out that the evolution of needle materials has always centered on the core medical ethics of "achieving better therapeutic effects with minimal trauma", and the integration of new materials and technologies will promote the transformation of injection needles from passive drug delivery tools to active intelligent medical terminals.

Keywords: Subcutaneous injection needle; Materials science; Biocompatibility; Surface engineering; Technological innovation

1. Introduction: The Material Revolution in Miniature Instruments

As one of the most basic and widely used instruments in the medical field, the evolution history of the material technology of subcutaneous injection needles is almost a miniature history of modern materials science development. Since Charles Pravaz and Alexander Wood invented the first generation of syringes in the mid-19th century, the material selection of injection needles has developed from simple metal processing to a high-tech field involving interdisciplinary integration of biocompatibility, mechanical properties, surface treatment and other aspects.

2. Technical Logic of the Stainless Steel-dominated Era

At present, austenitic stainless steel (especially 304 and 316L medical-grade stainless steel) accounts for about 85% of the global subcutaneous injection needle market, and there is a profound scientific and engineering logic behind this dominant position.

First, from the perspective of biocompatibility, medical stainless steel forms a dense chromium oxide (Cr₂O₃) passive film with a thickness of only 3-5 nanometers on the surface by precisely controlling the chromium (Cr) content (usually 16-18%). This film has self-healing properties; even if slightly scratched, it can be quickly reconstructed in an oxygen-rich environment. A 2018 study in the Journal of Biomaterials pointed out that this passive film makes the ion release rate of stainless steel needles when in contact with biological fluids lower than 0.1μg/cm²/week, which is much lower than the human metabolic clearance threshold.

In terms of mechanical properties, needle manufacturing faces the challenge of a "strength-toughness-elasticity" triangular balance. The wall thickness of the needle tube is usually only 0.1-0.15mm, but it has to bear the combined load of longitudinal puncture force and transverse bending force. Modern cold rolling technology can refine the stainless steel grain size to 5-10 microns, enabling the tensile strength to reach 850-1000MPa while maintaining an elongation of 15-20%. This "grain refinement strengthening" technology has made 33G (outer diameter 0.21mm) ultra-fine needles possible, with pain sensation reduced by more than 60% compared with traditional 27G needles.

3. Precise Application Scenarios of Special Alloys

In specific medical scenarios, nickel-chromium alloys and cobalt-chromium alloys show unique advantages. For example, Hastelloy containing molybdenum is used in long-term implantable drug delivery systems, and its corrosion resistance is more than 100 times that of stainless steel. A 2021 study by the Mayo Clinic showed that the level of inflammatory factors of insulin pump infusion needles using special alloys after 7 days of subcutaneous indwelling was only 1/3 of that of stainless steel needles.

The innovative application of shape memory alloys (especially Nitinol) is changing the field of interventional therapy. This alloy has superelasticity below the phase transition temperature, can be delivered into the human body through a 25G needle (0.5mm), and restores the preset shape under the action of body temperature. The latest neurointerventional catheters have achieved a compression ratio of "1.2mm expanded diameter / 0.3mm delivery diameter", making percutaneous puncture treatment of intracranial aneurysms a routine minimally invasive surgery.

4. Breakthrough Progress in Polymer Materials

The breakthrough of medical-grade polymer needles comes from three key technologies: nano-reinforcement technology, gas barrier coating and controllable degradation design.

After being reinforced with carbon nanotubes, the flexural modulus of polyetheretherketone (PEEK) can reach 15GPa, close to the level of titanium alloy. A 2023 report in Advanced Healthcare Materials showed that a PEEK composite needle developed by a German company exhibited 30% higher imaging clarity than metal needles under B-ultrasound guidance.

The development of biodegradable polymer needles is particularly striking. Polylactic-co-glycolic acid (PLGA) needles can stay under the skin for 4-8 weeks, release drugs continuously and then degrade completely. The "star-shaped microneedle array" developed by a team from the Massachusetts Institute of Technology consists of 16 biodegradable needle tips, each of which can carry different drugs to achieve precise time-sequenced controlled release.

5. The Microcosm of Surface Engineering

Modern needle surface treatment has entered the era of nanoscale precision. Diamond-like carbon (DLC) coating can reduce the friction coefficient from 0.6 to below 0.1, reducing puncture resistance by 40%. The "nano-sliding three-layer coating" developed by Terumo Corporation of Japan forms a gradient lubricating layer within 3mm of the needle tip, reducing the Visual Analog Scale (VAS) pain score of intradermal injection with a puncture depth of 1.5mm from 4.2 to 2.1.

Antibacterial surface technologies include silver nanoparticle coating, photocatalytic titanium dioxide coating, etc. Researchers in South Korea developed "Laser-Induced Periodic Surface Structures (LIPSS)", which form periodic grooves with a width of 200-500 nanometers on the needle surface, reducing the bacterial adhesion rate by 99.7% without affecting blood compatibility.

6. Future Trends of Technology Integration

Intelligent responsive materials represent the next development direction. The temperature-sensitive hydrogel coating remains solid at room temperature for easy puncture, and swells to form a "biological sealing layer" after entering the human body to prevent drug reflux. The pH-sensitive coating releases antibiotics when encountering the acidic environment of the infected site.

The integrated structure-function design is breaking through the traditional needle tube shape. The "honeycomb bionic needle tube" developed by Boston Scientific Corporation reduces the wall thickness by 30% while increasing the bending strength by 50%. The "vibratory puncture needle" designed inspired by mosquito mouthparts reduces the puncture force by 80% with micro-vibration at 150Hz.

7. Conclusion: The Return of Medical Value of Material Innovation

Every material progress corresponds to a substantial improvement in clinical benefits. From the reduction of pain perception, to the improvement of injection accuracy, and then to the innovation of treatment models, the material evolution of subcutaneous injection needles has always centered on the core medical ethics of "achieving better therapeutic effects with minimal trauma". In the future, with the further integration of nanotechnology, biomimetic technology and intelligent materials, injection needles will transform from a passive drug delivery tool to an intelligent medical terminal that actively participates in the treatment process.